ORTEXORTEX News
Tracking CPNG? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CP
Trader NoteCPNG

Coupang Jumps 9% Post-Earnings as Citi Upgrades to Buy

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 4 Nov 2026, 21:10

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CPNG delivered a sharp post-earnings rally this week, rising 9.5% to $15.23, and the market reaction has shifted the story from pre-print caution to whether the upgrade cycle that just started has further to run.

The most immediate catalyst is a fresh rating change from Citigroup. Paul Hwang upgraded CPNG to Buy from Neutral on November 4, keeping his $19 target in place. That target still sits 25% above the current price, but it represents the first upgrade from a major Wall Street firm since Deutsche Bank moved to Buy in August. The broader Street picture remains constructive but under pressure on price. BofA Securities has trimmed its target twice in 2026, landing at $24. Barclays held Overweight with a $29 target in July. Deutsche Bank sits at $21.50. Consensus mean sits near $23.34, implying more than 50% upside from current levels. The Street broadly believes in the recovery thesis; it keeps marking the timeline down while holding the ratings. EPS surprise ranks at the 100th percentile, and 30-day EPS momentum ranks in the top percentile as well, though the 90-day figure scores near zero, a sign that estimate revisions have been lumpy rather than consistent. The P/E multiple is running at 94x on current figures, while EV/EBITDA has drifted lower over the past month, sitting near 15.6x.

Short positioning tells a quietly bullish side-story. Shorts have been covering steadily. Short interest has fallen roughly 7% over the past month, dropping from around 82 million shares in mid-October to 74.5 million, now representing 4.5% of the free float. That is an active unwind, not drift. The lending market is entirely relaxed: availability is running near 8,820%, meaning the pool of shares available to borrow dwarfs the amount currently on loan by an enormous margin. Borrowing cost is 0.42%, near its lowest in recent weeks and consistent with no meaningful borrow squeeze pressure. Options sentiment is modestly bullish. The put/call ratio is 0.22, barely above its 20-day average of 0.21 and well below the 52-week high of 0.63. There is no sign of defensive hedging; options traders appear comfortable holding the upside.

Ownership is dominated by a small number of large, long-term holders. SoftBank's SB Investment Advisers (UK) Limited holds 16.1% of shares, a position that has not changed recently. Founder Bom Kim holds 8.8%. Baillie Gifford trimmed its stake from 7.2% to 4.8% in its most recent 13G/A filing, though it remains a top holder at 78.7 million shares. Dodge & Cox added 1.5 million shares through September and now holds 4%. Artisan Partners made the largest recent move in percentage terms, adding 16.8 million shares to hold 2.8% as of June. Aspex Management and Point72 each added more than 14 million shares in the same period. None of the five-percent holders carry a 13D activist flag; all large stakes are filed as passive 13G positions. On the insider side, the only open-market activity in the past 90 days was a planned sale of 5,519 shares by Chief Accounting Officer Jonathan Lee in October under a 10b5-1 plan. The net insider position over 90 days is a modest $3.3 million in disposals, all pre-scheduled, and not a signal of conviction either way.

One real-economy data point is worth noting without over-reading. Coupang's buyback spend has risen for four consecutive quarters, reaching $459 million in the quarter ending April 2026. That is a streak worth tracking, but none of the available alt data datasets for CPNG have been measured as leading indicators of reported financials, so the buyback trend stands as colour on capital allocation discipline rather than a pointer to the next print.

The gap between the current price and the analyst consensus target of $23.34 remained wide before this week's move and is still wide after it. The next earnings print is not until late February 2027, leaving 111 days for the market to decide how much of that gap reflects discount or doubt. What to watch in the near term is whether the Citi upgrade triggers further analyst re-ratings, and whether the short-cover trend that has been running since mid-October continues or stabilises at current levels.

Stocks in this article

See the live data behind this article on ORTEX.

Open CPNG on ORTEX →

How this article was generated

Generated
4 Nov 2026, 21:14
Data as of
4 Nov 2026, 21:10
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.